Arctic Bioscience creates scientifically documented health-promoting products based on herring roe. Our portfolio consists of high DHA marine omega-3 phospholipid extracts and proteins for pharmaceutical and nutraceutical applications.
The ongoing development of a treatment for mild-to-moderate psoriasis (HRO350) would improve the quality of life for this patient group significantly. Psoriasis patients have limited treatment options today, many of which having considerable side-effects. HRO350 could be the first oral treatment for psoriasis globally without reported side effects.